Literature DB >> 30341932

Changing trends in surgery for abdominal Crohn's disease.

D Mege1, K Garrett1, J Milsom1, T Sonoda1, F Michelassi1.   

Abstract

AIM: The introduction of biological agents and laparoscopy are, arguably, the most important developments for the treatment of Crohn's disease (CD) in the last two decades. Due to the efficacy of biological agents in treating mild disease, it is likely that the percentage of surgery for complex cases may have increased. The objective of this study was to analyse the changing characteristics and results of the surgical treatment of patients with CD over the past 13 years.
METHODS: All patients who underwent abdominal surgery for CD between 2004 and 2016 were retrospectively identified. Data were compared between two periods (2004-2010 and 2011-2016).
RESULTS: A total of 908 procedures were performed (48% men, mean age 43 ± 16 years). Demographic and CD characteristics changed significantly over time: comorbidities were more frequent (35% vs 46%, P < 0.0001), and preoperative steroids (28% vs 36%, P < 0.01) and anti-tumour necrosis factor (20% vs 40%, P < 0.0001) treatments were more frequently used in the second period. Smoking (14% vs 8%, P < 0.0001) and use of immunosuppressors (32% vs 22%, P < 0.001) decreased significantly. More cases of penetrating disease (22% vs 32%, P < 0.001) were operated upon in the second period. The laparoscopic approach (49% vs 57%, P < 0.04) was more frequently performed and mean blood loss (167 ± 222 vs 123 ± 243 ml, P < 0.01) decreased significantly. Postoperative morbidity did not change between the two periods.
CONCLUSION: Despite a higher incidence of comorbidities and the use of biologics postoperative morbidity remained unchanged. An increased use of laparoscopy and a decreased intra-operative blood loss may have contributed to offsetting the impact of increased comorbidity. Colorectal Disease
© 2018 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Crohn's disease; laparoscopy; recurrence

Mesh:

Year:  2018        PMID: 30341932     DOI: 10.1111/codi.14450

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  5 in total

1.  Safety and feasibility of repeat laparoscopic colorectal resection: a matched case-control study.

Authors:  Alban Zarzavadjian le Bian; Laurent Genser; Christine Denet; Carlotta Ferretti; Anais Laforest; Jean-Marc Ferraz; Candice Tubbax; Philippe Wind; Brice Gayet; David Fuks
Journal:  Surg Endosc       Date:  2019-07-19       Impact factor: 4.584

2.  Strictureplasty versus bowel resection for the surgical management of fibrostenotic Crohn's disease: a systematic review and meta-analysis.

Authors:  Waqas T Butt; Éanna J Ryan; Michael R Boland; Eilis M McCarthy; Joseph Omorogbe; Karl Hazel; Gary A Bass; Paul C Neary; Dara O Kavanagh; Deirdre McNamara; James M O'Riordan
Journal:  Int J Colorectal Dis       Date:  2020-02-11       Impact factor: 2.571

3.  Early real-world effectiveness of ustekinumab for Crohn's disease.

Authors:  Richard James Harris; Martin McDonnell; David Young; Marion Bettey; Louise Downey; Lucinda Pigott; Richard Felwick; Markus Gwiggner; J R Fraser Cummings
Journal:  Frontline Gastroenterol       Date:  2019-05-29

4.  PREDICTIVE FACTORS FOR LOSS OF RESPONSE TO ANTI-TNF IN CROHN'S DISEASE.

Authors:  Byanca Rossetti Moreira Dos Santos; Carlos Henrique Marques Dos Santos; Vitória Rossetti Moreira Dos Santos; Claudia Yanina Garcia Torrez; Daniel Palomares-Junior
Journal:  Arq Bras Cir Dig       Date:  2020-11-20

5.  Crohn's disease: a population-based study of surgery in the age of biological therapy.

Authors:  Christian Stöss; Maximilian Berlet; Stefan Reischl; Ulrich Nitsche; Marie-Christin Weber; Helmut Friess; Dirk Wilhelm; Philipp-Alexander Neumann
Journal:  Int J Colorectal Dis       Date:  2021-04-19       Impact factor: 2.571

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.